Aucentra Therapeutics is delighted to announce the appointment of Professor Chris Pepper to our Scientific Advisory Board. Prof Chris Pepper is the Chair in Cancer Research at the Brighton and Sussex Medical School, UK.
His research career has been extensive and patient-focused, with over 100 papers published in high impact factor journals. His team was the first to demonstrate the clinical importance of the BCL2 family of proteins and the transcription factor NF-κB in modulating disease progression and response to drugs. His main area of focus has been B-cell lymphocytic leukemia, a research field which he has made significant contributions to. Professor Pepper is also an author of 9 global patents as co-founder of TeloNostiX.
We at Aucentra are very lucky and excited to have him on board – welcome Chris!